Australia markets close in 17 minutes

Luyan Pharma Co.,Ltd. (002788.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
7.97+0.11 (+1.40%)
As of 01:40PM CST. Market open.
Currency in CNY

Valuation measures4

Market cap (intra-day) 3.05B
Enterprise value 7.63B
Trailing P/E 8.27
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.15
Price/book (mrq)1.01
Enterprise value/revenue 0.38
Enterprise value/EBITDA 10.96

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 3-14.00%
S&P500 52-week change 325.87%
52-week high 310.19
52-week low 36.10
50-day moving average 38.52
200-day moving average 38.81

Share statistics

Avg vol (3-month) 34.58M
Avg vol (10-day) 33.89M
Shares outstanding 5388.52M
Implied shares outstanding 6388.52M
Float 8231.41M
% held by insiders 142.78%
% held by institutions 12.65%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.3
Forward annual dividend yield 43.75%
Trailing annual dividend rate 30.30
Trailing annual dividend yield 33.82%
5-year average dividend yield 42.49
Payout ratio 431.58%
Dividend date 3N/A
Ex-dividend date 414 June 2023
Last split factor 21.7:1
Last split date 329 May 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 1.82%
Operating margin (ttm)3.16%

Management effectiveness

Return on assets (ttm)3.72%
Return on equity (ttm)12.51%

Income statement

Revenue (ttm)20.14B
Revenue per share (ttm)52.06
Quarterly revenue growth (yoy)6.10%
Gross profit (ttm)N/A
EBITDA 752.95M
Net income avi to common (ttm)367.45M
Diluted EPS (ttm)0.95
Quarterly earnings growth (yoy)4.90%

Balance sheet

Total cash (mrq)458.14M
Total cash per share (mrq)1.18
Total debt (mrq)5.04B
Total debt/equity (mrq)165.53%
Current ratio (mrq)1.16
Book value per share (mrq)7.76

Cash flow statement

Operating cash flow (ttm)1.09B
Levered free cash flow (ttm)348.02M